Welcome to the Working Group on New TB Drugs Blog
USAID Head: TB Drug Research Critical in Turning Tide Against Epidemic
Dr. Rajiv Shah, Administrator of the United States Agency for International Development (USAID) presented the most recent David E. Barmes Global Health Lecture on Tuesday, February 15, 2011 on the NIH Campus in Bethesda, Maryland.
Interview with Dr. Anneke Hesseling – Part Three
An interview with Dr. Anneke Hesseling, the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa.
Interview with Dr. Anneke Hesseling – Part Two
An interview with Dr. Anneke Hesseling, the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa.
Interview with Dr. Anneke Hesseling – Part One
An interview with Dr. Anneke Hesseling, the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa.
First Novel Regimen Clinical Trial Featured on South African TB
The clinical trial of the first novel regimen was featured today on SABC TV in South Africa. This is the first clinical trial to test multiple new TB drugs in combination; the trial is known as New Combination 1 (NC001). The experimental regimen undergoing testing in this trial consists of experimental TB drugs PA-824, Moxifloxacin, and Pyrazinamide, an antibiotic commonly administered as part of current TB treatment.
TB Alliance Launches First Clinical Trial of a Novel TB Drug Regimen
Today, the TB Alliance announced the first clinical trial to test multiple new TB drugs in combination; the trial is known as New Combination 1 (NC001).The experimental regimen undergoing testing in this trial consists of experimental TB drugs PA-824, Moxifloxacin, and Pyrazinamide, an antibiotic commonly administered as part of current TB treatment. This regimen has shown potential to harmonize treatment for TB drug-sensitive tuberculosis (DS-TB) and multidrug-resistant tuberculosis (MDR-TB) under a single three-drug regimen.
MSF Podcast: Difficulties of Treating Children with TB
From MSF: In Mathare, a poor area on the outskirts of Nairobi, MSF treats children with TB, but just diagnosing them is extremely challenging. Results of the lack of research into TB means the main diagnostic tool for the adult form of the disease is 130 years old and not at all adapted for use with children.
Posted in TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Interview with Dr. Lee Reichman – Part Three
This is part three of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.
-
You are currently browsing the archives for the Video category.
-
Toppix TB News- Editorial: Lives at risk if the U.S. shortchanges Global Fund 4 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- WHO says TB in Russia displays highest known drug resistance 3 Feb 2012
- Media outlets examine Global Fund's future as it enters second decade 3 Feb 2012
